Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UC-MSC for HBV-related liver cirrhosis
NCT04357600Phase 2Enrolling by invitation
- Sponsor
- Prodia Stem Cell Indonesia
- Start
- May 2018
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
A Phase 2 trial of allogeneic umbilical cord mesenchymal stem cells in Liver cirrhosis (LC), sponsored by Prodia Stem Cell Indonesia. Started May 2018; status: enrolling by invitation.
02
Drugs
allogeneic umbilical cord mesenchymal stem cells
03
Conditions
Liver cirrhosis (LC)
Beyond the preview
Go deeper on NCT04357600.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04357600.